Healio
Healio

Sitemap

December 17, 2020 Articles

Filter by Available Specialty

Filter by specialty

  1. ALPHEUS
  2. Asenapine patch efficacious, safe for adults with schizophrenia
  3. BLOG: How COVID-19 took us out of our comfort zone
  4. Bruder develops kit for ocular surgery prep
  5. Cell therapy reduces cardiac death, has no effect on nonfatal heart failure events
  6. Changes in smell, taste occur frequently with COVID-19, sometimes prior to other symptoms
  7. COVID-19 causes ‘profound’ drop in transplant rates in US, but system shows ‘resilience’
  8. Duloxetine plus usual care cost effective in moderate-pain knee OA
  9. FDA accepts Takeda’s NDA, grants review for budesonide oral suspension
  10. FDA approves Benlysta, first treatment for lupus nephritis
  11. FDA approves Riabni, third biosimilar to Rituxan
  12. FDA committee recommends authorizing use of second COVID-19 vaccine in US
  13. FDA grants priority review to Keytruda-chemotherapy regimen for esophageal cancer
  14. FDA releases performance criteria for spinal plating systems
  15. FIDELIO-DKD
  16. GALACTIC-HF
  17. Getting to the heart of CV outcomes in rheumatic disease
  18. HARP-MINOCA
  19. INVESTED
  20. Limited data exist for psoriasis treatment in pregnant women
  21. Long chest compression pauses in pediatric in-hospital cardiac arrest may worsen survival
  22. Long-term exposure to air pollution may increase risk for kidney disease
  23. Mortality due to COVID-19 elevated in patients with preexisting ILD
  24. NICE issues recommendation for Beovu for wet AMD
  25. OK to use extra COVID-19 vaccine doses found in vials, FDA says
  26. Progress in vaccinating children against measles has slowed in LMICs
  27. Q&A: ACAAI releases guidance about Pfizer's COVID-19 vaccine in patients with allergies
  28. Q&A: ‘Incredibly cost-effective’ tool facilitates safer opioid prescribing
  29. Q&A: The importance of ‘high-quality targeted temperature management’ in post-arrest care
  30. Relationship of HIV severity, endothelial function may predict additional CVD risk
  31. Report calls for global action to reduce EDC exposure from plastics
  32. RIVER
  33. SCOPE 2
  34. Selective progesterone receptor modulator may help treat premenstrual dysphoric disorder
  35. Serum markers, next-generation sequencing may diagnose infection in orthopedic surgery
  36. STRENGTH
  37. Study on patient-reported outcomes for MIGS underway
  38. Tocilizumab may lower risk for COVID-19 progression, but not mortality
  39. Top in hem/onc: Highlights from hematology, breast cancer meetings
  40. Umbralisib-ublituximab combination extends PFS in CLL
  41. VIDEO: ‘Real world’ data for patients with HER2-positive, BRCA1/2 breast cancer
  42. VIDEO: Benefits, shortcomings of virtual format for ASH
  43. VIDEO: Camidanlumab tesirine appears active in relapsed, refractory Hodgkin lymphoma
  44. VIDEO: Circulating tumor DNA possible biomarker for relapse in DLBCL
  45. VIDEO: Expert discusses ‘practice-changing’ findings from RxPonder study
  46. VIDEO: Expert discusses CLL highlights from ASH
  47. VIDEO: Expert discusses positives, negatives from virtual SABCS meeting, RxPonder data
  48. VIDEO: Oral selective estrogen receptor degrader may benefit some breast cancer patients
  49. VIDEO: Pembrolizumab plus GVD ‘seems like a win’ in Hodgkin lymphoma
  50. VIDEO: PET-guided strategy improves safety of advanced Hodgkin lymphoma treatment
  51. VIDEO: Post-transplant consolidation with nivolumab, brentuximab shows promise in Hodgkin lymphoma
  52. VIDEO: Treatment for older Hodgkin lymphoma patients is ‘an area of unmet need’
  53. VIDEO: Virtual AIBD provides new opportunities
  54. Younger age at type 2 diabetes diagnosis drives greater mortality, CV risk